Skip to main content
. 2021 Mar 29;10(7):1376. doi: 10.3390/jcm10071376

Table 2.

Distribution of QFT-Plus and TB-Feron IGRA results and agreement between the groups.

IGRA Patterns Overall (%)
(n = 335)
ATB (%)
(n = 40)
P-LTBI (%)
(n = 75)
H-LTBI (%)
(n = 70)
HC (%)
(n = 150)
Overall positivity of QFT-Plus 168 (50.1) 36 (90.0) 63 (84.0) 69 (98.6) 0 (0.0)
Overrall Positivity of TB-Feron 178 (53.1) 35 (87.5) 68 (90.7) 68 (97.1) 7 (4.7)
Q-Positive T-Positive 164 34 63 67 0
TB1+ and TB2+ 158 (96.4) 31 (91.2) 63 (100) 64 (95.5) 0 (0.0)
TB1 alone 2 (1.2) 0 (0.0) 0 (0.0) 2 (3.0) 0 (0.0)
TB2 alone 4 (2.4) 3 (8.8) 0 (0.0) 1 (1.5) 0 (0.0)
Q-Positive T-Negative 4 2 0 2 0
TB1+ and TB2+ 3 (66.7) 2 (100) 0 (0.0) 1 (50.0) 0 (0.0)
TB1 alone 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
TB2 alone 1 (33.3) 0 (0.0) 0 (0.0) 21(50.0) 0 (0.0)
Q-Negative T-Positive 14 1 5 1 7
Q-Negative T-Negative 151 3 5 0 143
Q-Negative T-Indeterminate 2 0 2 0 0
Agreement of each group (%) 94.0 92.5 90.7 95.7 95.3

Abbreviation: IGRA, interferon-gamma-releasing assay; QFT-Plus and Q, QuantiFERON-TB Gold Plus; T, TB-Feron; TB1 or 2, TB antigen tube 1 or 2; ATB, active tuberculosis; P-LTBI, patients with immunocompromised status and latent TB infection; H-LTBI, health care workers with latent TB infection; HC, health care workers confirmed with previous negative IGRA and low risks.